BusinessAXIM Biotech to Present at Rodman & Renshaw 19th Annual Global Investment Conference in New York CityBy Nasdaq OMXSep 7, 2017, 1:00 PM UTC
BusinessAnthera Pharmaceuticals Surpasses 50% Milestone for Screening of Patients in RESULT Phase 3 Clinical Study of Sollpura in Cystic FibrosisBy Nasdaq OMXSep 7, 2017, 12:30 PM UTC
BusinessAlder BioPharmaceuticals® to Present Data from Eptinezumab Development Program at 18th Congress of the International Headache SocietyBy Nasdaq OMXSep 7, 2017, 12:30 PM UTC
BusinessIntra-Cellular Therapies Announces Positive Topline Data From 6-Week Open-label Safety Switching Study with Lumateperone in Patients with SchizophreniaBy Nasdaq OMXSep 7, 2017, 11:00 AM UTC
BusinessAnthera Pharmaceuticals to Present at Rodman & Renshaw’s 18th Annual Global Investment ConferenceBy Nasdaq OMXSep 6, 2017, 12:30 PM UTC
BusinessVital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of DirectorsBy Nasdaq OMXSep 6, 2017, 12:01 PM UTC
BusinessCytoDyn Provides Further Update on PRO 140 Pivotal Combination Therapy Trial in Patients with HIVBy Nasdaq OMXSep 6, 2017, 10:00 AM UTC
BusinessAmarin to Present at Rodman & Renshaw’s Global Investment ConferenceBy Nasdaq OMXSep 6, 2017, 10:00 AM UTC
